Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Enanta Pharmaceuticals (ENTA) Times Interest Earned (2016 - 2025)

Enanta Pharmaceuticals filings provide 9 years of Times Interest Earned readings, the most recent being -$3.65 for Q4 2025.

  • On a quarterly basis, Times Interest Earned rose 69.58% to -$3.65 in Q4 2025 year-over-year; TTM through Dec 2025 was -$8.3, a 28.84% increase, with the full-year FY2025 number at -$11.11, changed 0.11% from a year prior.
  • Times Interest Earned hit -$3.65 in Q4 2025 for Enanta Pharmaceuticals, up from -$7.7 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of -$3.65 in Q4 2025 to a low of -$18.38 in Q2 2023.
  • Median Times Interest Earned over the past 3 years was -$11.57 (2024), compared with a mean of -$11.12.
  • Biggest five-year swings in Times Interest Earned: dropped 18.36% in 2024 and later surged 69.58% in 2025.
  • Enanta Pharmaceuticals' Times Interest Earned stood at -$10.14 in 2023, then fell by 18.36% to -$12.0 in 2024, then surged by 69.58% to -$3.65 in 2025.
  • The last three reported values for Times Interest Earned were -$3.65 (Q4 2025), -$7.7 (Q3 2025), and -$11.68 (Q2 2025) per Business Quant data.